致泻性大肠埃希菌感染与反应性关节炎及肌肉骨骼症状的关联
前瞻性研究纳入526名国际旅行者,分析致泻性大肠埃希菌(DEC)获得与反应性关节炎(ReA)及其他反应性肌肉骨骼(MSK)症状的关联。224名完成全部问卷和粪便检测者中38人(17.0%)报告MSK症状,DEC获得与MSK症状相关(OR 3.9;95% CI 1.2至13.3)。仅DEC阳性者中ReA发生率低且临床表现轻微,抗生素治疗腹泻未预防MSK症状发生。
要点
- DEC获得与旅行后MSK症状风险升高相关(OR 3.9;95% CI 1.2至13.3)。
- 仅DEC阳性者中ReA发生率为2.6%,临床表现多为轻微。
- 抗生素治疗旅行者腹泻未预防MSK症状发生。
核心结论
- DEC获得与旅行后肌肉骨骼症状风险升高相关,但ReA发生率低且临床表现轻微。
- 抗生素治疗旅行者腹泻未预防MSK症状发生。
研究设计与样本
- 前瞻性研究纳入526名国际旅行者,要求提供旅行前后粪便样本并填写问卷(旅行前、旅行后及3周随访)。
- 采用多重定量PCR检测五种DEC及沙门菌、志贺菌、弯曲杆菌、耶尔森菌和霍乱弧菌。
- 对返回全部问卷和粪便标本的224名志愿者进行分析,采用多因素分析识别MSK症状易感因素。
主要发现
- 224名完成全部问卷和粪便检测的志愿者中38人(17.0%)报告MSK症状。
- 多因素分析显示DEC获得与MSK症状相关(OR 3.9;95% CI 1.2至13.3)。
- 151名仅DEC阳性者中4人(2.6%)患ReA,2人(1.3%)反应性肌腱炎,3人(2.0%)反应性关节痛。
- ReA多轻微,所有ReA患者HLA-B27阴性。
- 抗生素治疗旅行者腹泻未预防MSK症状发生。
关键数值与推荐
- DEC获得与MSK症状的OR为3.9(95% CI 1.2至13.3)。
- 仅DEC阳性者中ReA发生率为2.6%(4/151),反应性肌腱炎1.3%(2/151),反应性关节痛2.0%(3/151)。
临床怎么用
- 国际旅行者获得DEC后应关注反应性肌肉骨骼症状的出现。
- 抗生素治疗旅行者腹泻不应以预防MSK症状为目的。
局限性
- 仅224名志愿者返回全部问卷和粪便标本,存在失访可能。
- ReA病例数少,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Using a prospective research design, we evaluated the association between acquisition of diarrhoeagenic Escherichia coli (DEC) and development of reactive arthritis (ReA) and other reactive musculoskeletal (MSK) symptoms among international travellers. METHODS: A total of 526 study participants were asked to provide pretravel and post-travel stool samples and fill in questionnaires (pretravel, post-travel and 3-week follow-up). A multiplex quantitative PCR assay was deployed to detect five DEC comprising enteroaggregative E. coli, enteropathogenic E. coli, enterotoxigenic E. coli, enterohaemorrhagic E. coli and enteroinvasive E. coli and Salmonella, Shigella, Campylobacter, Yersinia, and Vibrio cholerae. Multivariate analysis was employed to identify factors predisposing to MSK symptoms. New post-travel MSK symptoms reported by participants with DEC were assessed by phone interviews and, if needed, clinically confirmed. RESULTS: From among the total of 224 volunteers who returned all questionnaires and stool specimens, 38 (17.0%) reported MSK symptoms. Multivariate analysis revealed that acquisition of DEC was associated with MSK symptoms (OR 3.9; 95% CI 1.2 to 13.3). Of the 151 with only-DEC, four (2.6%) had ReA, two (1.3%) reactive tendinitis and three (2.0%) reactive arthralgia. ReA was mostly mild, and all patients with ReA were negative for human leucocyte antigen B27. Antibiotic treatment of travellers' diarrhoea did not prevent development of MSK symptoms. CONCLUSION: A total of 17% of volunteers reported post-travel MSK symptoms. DEC acquisition was associated with an increased risk of developing them, yet the ReA incidence remained low and the clinical picture mild. Antibiotic treatment did not protect against development of MSK symptoms.
引用
- Tuompo R, Lääveri T, Hannu T, et al. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC). Ann Rheum Dis. 2020. PMID: 32179576. doi:10.1136/annrheumdis-2019-216736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。